# Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

> **NCT01345539** · PHASE2 · TERMINATED · sponsor: **Steven Burton** · enrollment: 24 (actual)

## Conditions studied

- Oligometastatic Disease

## Interventions

- **RADIATION:** Stereotactic Radiosurgery (SRS)
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT01345539
- **Lead sponsor:** Steven Burton
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06-07
- **Primary completion:** 2022-05-03
- **Final completion:** 2022-10-20
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Participant enrollment was negatively impacted by medical oncology treatment with systemic therapy alone and accrual to other clinical trials.
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01345539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01345539, "Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT01345539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*